Actuación diagnóstica ante hipertransaminasemia en pediatría: documento de consenso de Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica (SEGHNP), Asociación Española de Pediatría de Atención Primaria (AEPap) y Sociedad Española de Pediatría de Atención Primaria (SEPEAP)

  1. Ignacio Ros Arnal
  2. Joaquín Reyes Andrade
  3. María Mercadal Hally
  4. Luis Carlos Blesa Baviera
  5. Diana García Tirado
  6. Samuel Héctor Campuzano Martín
  7. Estela de la Calle Navarro
  8. Ana María Vegas Álvarez
Aldizkaria:
Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP )

ISSN: 1695-4033 1696-4608

Argitalpen urtea: 2022

Alea: 96

Zenbakia: 5

Orrialdeak: 448-448

Mota: Artikulua

DOI: 10.1016/J.ANPEDI.2022.04.002 DIALNET GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP )

Laburpena

Hypertransaminasemia is a frequent finding in pediatrics, which could reflect potentially treatable serious disease. The aim of this document is to establish, by reviewing the available evidence, a consensus for an adequate management of hypertransaminasemia, from its detection until the study is complete. To this end, a working group was formed with the participation of members of the Society of Pediatric Gastroenterology, Hepatology and Nutrition (SEGHNP), the Spanish Association of Primary Care Pediatrics (AEPap) and the Spanish Society of Primary Care Pediatrics (SEPEAP). Twenty-one recommendations are established with a marked practical component that will be useful in hospital clinical practice and primary care.